Akero Therapeutics, Inc.
Pharmaceutical company · South San Francisco, California, United States
Akero Therapeutics, Inc. is a pharmaceutical company headquartered in South San Francisco, California, United States. Its earliest recorded incorporation is in 2017. It has reported private securities offerings to the US SEC, most recently $45 million sold in a notice filed in 2018.
Akero Therapeutics at a glance
What does Akero Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $45.5 million sold (2018).
Frequently asked questions about Akero Therapeutics
Where is Akero Therapeutics headquartered?
Akero Therapeutics, Inc. is headquartered in South San Francisco, California, United States.
What does Akero Therapeutics do?
Akero Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Akero Therapeutics founded?
The earliest incorporation on record for Akero Therapeutics, Inc. is in 2017, according to public company registers.
Similar companies
- CytomX Therapeutics, Inc.South San Francisco, California, United States
- Vistagen Therapeutics, Inc.South San Francisco, California, United States
- Portola Pharmaceuticals IncSouth San Francisco, California, United States
- IDEAYA Biosciences, Inc.South San Francisco, California, United States
- Spruce Biosciences, Inc.South San Francisco, California, United States
- Meissa Vaccines IncSouth San Francisco, California, United States
- Oric Pharmaceuticals, Inc.South San Francisco, California, United States
- GigaGen, Inc.South San Francisco, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.